GC Cell
144510.KQ
16.41 USD
-0.17
-1.03%
g
Overview
Last close
16.41 usd
Market cap
246.64M usd
52 week high
36.44 usd
52 week low
14.82 usd
Target price
50.71 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9268
Price/Book Value
0.684
Enterprise Value
314.10M usd
EV/Revenue
2.4861
EV/EBITDA
31.8641
Key financials
Revenue TTM
126.40M usd
Gross Profit TTM
66.44M usd
EBITDA TTM
6.94M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
656.87B usd
Net debt
N/A usd
About
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.
- Symbol144510.KQ
- ExchangeKQ
- IsinKR7144510005
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOJong-Eun Park
- HeadquarterYongin-si
- Web sitehttps://www.gccell.com
